Can intravenous iron therapy meet the unmet needs created by the new restrictions on erythropoietic stimulating agents?

Transfusion
Aryeh ShanderMichael Auerbach

Abstract

In 2008, after reports of an association between erythropoietic stimulating agent (ESA) therapy and the potential for either thrombotic cardiovascular events or more rapid tumor progression in some cancers, the Food and Drug Administration changed the product labeling for ESAs, adding a black box warning as well as more restrictive indications, especially in oncology patients. In addition the Centers for Medicare and Medicaid Services has placed significant restrictions on payments for ESA therapy. These new limitations on ESA have led to increased use of transfusions in anemic cancer patients. This increase in allogeneic transfusions potentially will place an additional burden on the US blood supply. Although allogeneic blood transfusion is one answer to ESA restrictions, the use of intravenous iron therapy (IV iron) is another possible alternative. We will discuss the use of IV iron as primary therapy for anemia, the use of combination IV iron and ESA therapy to improve efficiency and decrease costs, and evidence that IV iron with and without ESA therapy can reduce allogeneic blood transfusions in surgical patients. We will also review the available IV iron agents and their comparative safety profiles.

References

Apr 1, 1988·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·M KaisiJ Rogers
Jul 1, 1995·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·S FishbaneJ Maesaka
Feb 1, 1996·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·D S SilverbergM Blum
Feb 1, 1996·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·F SepandjD Hirsch
Jun 1, 1996·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·J E TaylorA G Morgan
Feb 11, 1999·The Journal of Bone and Joint Surgery. American Volume·B E BierbaumR B Welch
Mar 10, 1999·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·G Faich, J Strobos
Feb 14, 2002·The Journal of Surgical Research·James R DunneLena M Napolitano
Apr 23, 2002·Kidney International·Beckie MichaelUNKNOWN Ferrlecit Publication Committee
May 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anders OsterborgUNKNOWN Epoetin Beta Hematology Study Group
Oct 9, 2003·Kidney International. Supplement·Daniel A BlausteinMorrell M Avram
Nov 18, 2003·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·J O KomolafeS O Ogunniyi
Feb 12, 2004·Clinical Pharmacokinetics·Lasse A LehtonenPertti J Pentikäinen
Feb 28, 2004·Nephron. Clinical Practice·Chaim CharytanBruce S Spinowitz
Mar 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael AuerbachJeevindra Rana
May 20, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Glenn M ChertowJarl Ahlmén
Aug 4, 2004·Emergency Radiology·G GayerR Zissin
Sep 29, 2004·Gynécologie, obstétrique & fertilité·D-E BrocheJ-J Terzibachian
Nov 4, 2004·Journal of Inorganic Biochemistry·Dina S KudashevaMary K Cowman
Mar 2, 2005·Best Practice & Research. Clinical Haematology·Joseph Wetherill Eschbach
Apr 28, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·George R BailiePeter L Lane
Aug 9, 2005·Expert Opinion on Emerging Drugs·John A Glaspy
Aug 10, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Brian Leyland-JonesEls Vercammen
Sep 8, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Gabriel MircescuNicolae Ursea
Nov 16, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Glenn M ChertowJarl Ahlmén
Dec 24, 2005·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Keyvan KarkoutiTerrence M Yau
May 9, 2006·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·UNKNOWN KDOQI, UNKNOWN National Kidney Foundation
Jul 13, 2006·Kidney International. Supplement·A Besarab
Sep 19, 2006·Journal of the American College of Cardiology·Aidan P BolgerCallum M Chapman
Oct 13, 2006·American Journal of Nephrology·Rajiv AgarwalAnatole Besarab
Nov 17, 2006·The New England Journal of Medicine·Ajay K SinghUNKNOWN CHOIR Investigators
Feb 10, 2007·Current Medical Research and Opinion·Paul CornesJean-Jacques Zambrowski
Feb 22, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James R WrightMark N Levine

❮ Previous
Next ❯

Citations

Apr 18, 2013·Best Practice & Research. Clinical Anaesthesiology·Gregory M T HareAryeh Shander
Dec 6, 2012·Journal of Women's Health·Arnold J FriedmanDavid van Wyck
Feb 5, 2016·The Cochrane Database of Systematic Reviews·Rahul MhaskarBenjamin Djulbegovic
May 13, 2011·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·David Baribeault, Michael Auerbach
Nov 26, 2011·Expert Review of Clinical Pharmacology·Isabelle Wauters, Johan Vansteenkiste
Sep 11, 2013·Transfusion·Aryeh ShanderDavid Henry
Apr 13, 2011·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Gregory M T HareKaterina Pavenski
May 16, 2014·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Maurice HoganToby Richards
Jan 13, 2012·The Mount Sinai Journal of Medicine, New York·Aryeh ShanderGregg Lobel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.